As for bladder cancer, a large study on patients with non-muscle-invasive bladder cancer who underwent intravesical bacillus Calmette–Guérin therapy after transurethral resection of bladder tumor looked into CRP and NLR as potential prognostic biomarkers for clinical outcomes [65]. The gene discussed is CRP; the disease is urinary bladder carcinoma.